$40.50▴ 0.80%
End-of-day close · 2026-06-23
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-208.79MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
-100.0%year over year
Weak
Revenue is contracting year over year.
Leverage
Lowdebt to assets
Healthy
A modest, well-covered debt load.
More coming: dilution / share-count creep.
✦ The read
Centessa Pharmaceuticals plc - American Depositary Shares is pre-profit. It is still burning cash while pre-profit. Revenue is contracting year over year. A modest, well-covered debt load.
Key numbers
Valuation
EPS (TTM)$-1.79
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.